Krystal Biotech, Inc. (KRYS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 4.53B |
| Enterprise Value | 4.00B |
| Trailing P/E | 72.81 |
| Forward P/E | 178.57 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 47.39 |
| Price/Book (mrq) | 5.67 |
| Enterprise Value/Revenue | 41.72 |
| Enterprise Value/EBITDA | 66.34 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.90 |
| 52-Week Change 3 | 80.05% |
| S&P500 52-Week Change 3 | 26.43% |
| 52 Week High 3 | 189.97 |
| 52 Week Low 3 | 86.03 |
| 50-Day Moving Average 3 | 168.38 |
| 200-Day Moving Average 3 | 130.06 |
Share Statistics
| Avg Vol (3 month) 3 | 395.38k |
| Avg Vol (10 day) 3 | 327.92k |
| Shares Outstanding 5 | 28.56M |
| Implied Shares Outstanding 6 | 28.56M |
| Float 8 | 20.75M |
| % Held by Insiders 1 | 12.76% |
| % Held by Institutions 1 | 91.37% |
| Shares Short (Apr 15, 2024) 4 | 2.45M |
| Short Ratio (Apr 15, 2024) 4 | 7.84 |
| Short % of Float (Apr 15, 2024) 4 | 11.35% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 8.59% |
| Shares Short (prior month Mar 15, 2024) 4 | 2.24M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 59.57% |
| Operating Margin (ttm) | 12.85% |
Management Effectiveness
| Return on Assets (ttm) | -4.97% |
| Return on Equity (ttm) | 8.87% |
Income Statement
| Revenue (ttm) | 95.95M |
| Revenue Per Share (ttm) | 3.45 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -50.61M |
| Net Income Avi to Common (ttm) | 57.16M |
| Diluted EPS (ttm) | 2.17 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 538.26M |
| Total Cash Per Share (mrq) | 18.85 |
| Total Debt (mrq) | 7.89M |
| Total Debt/Equity (mrq) | 0.99% |
| Current Ratio (mrq) | 12.65 |
| Book Value Per Share (mrq) | 28.02 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -46.76M |
| Levered Free Cash Flow (ttm) | -45.19M |
© 2024 Yahoo. All rights reserved.